A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma
Clinical trial NCT01970358 · COMPLETED
Trial details
- NCT number
- NCT01970358
- Sponsor
- Patrick Ott, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2015-09-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.